Neurology CME Courses, Case Studies | Online Neurologic CME

Neurology CME Courses

Neurology CME/CE Courses

myCMEYour search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.


Featured Courses

2021 Multiple Sclerosis Updates: A Focus on New and Emerging Therapies, Best Practices in Clinical Management and Key Considerations During the COVID-19 Era

2021 Multiple Sclerosis Updates: A Focus on New and Emerging Therapies, Best Practices in Clinical Management and Key Considerations During the COVID-19 Era | myCME

AMA PRA Category 1 Credit(s)TM
Although the multifactorial causes of multiple sclerosis (MS) are not known, an improved understanding of the neuroimmunologic pathogenesis has led to the development of a wide variety of disease-modifying treatments (DMTs). While there is no cure for MS, these treatments can reduce disease activity and delay MS progression and disability.
When and How to Switch Therapies in MS: Neurology Guideline Implementation and Expert Recommendation

When and How to Switch Therapies in MS: Neurology Guideline Implementation and Expert Recommendation | myCME

AMA PRA Category 1 Credit(s)TM
Medications such as immunomodulatory and immunosuppressive disease-modifying therapies (DMTs) can delay this damage and slow the resulting progressive phase, thus helping maintain quality of life for patients with Multiple Sclerosis. To make an informed decision, clinicians need to understand the rationale behind medication choices and the risks and benefits of DMTs available.
OFF to ON: Strategies to Manage OFF Episodes in Patients with Parkinson’s disease

OFF to ON: Strategies to Manage OFF Episodes in Patients with Parkinson’s disease | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s)
The activity will review information that community neurologists need to know about Parkinson’s disease (PD) motor fluctuations, including clinical manifestations, the role of gut absorption of levodopa on symptom patterns, the variety of established and newer therapeutic management strategies, and the need to involve patients in shared decision-making.
An Update on COVID-19 and MS: Disease-Modifying Therapies and COVID Vaccines

An Update on COVID-19 and MS: Disease-Modifying Therapies and COVID Vaccines | myCME

AMA PRA Category 1 Credit(s)TM
This program provides an update on our previous activity titled: Safe and Effective Use of MS Disease-Modifying Therapies During the COVID-19 Crisis by discussing updates on the impact of various MS disease-modifying therapies and risk of COVID infection, updates on the vaccines approved and in development to prevent COVID-19 infection, and special consideration for vaccine administration for patients on MS disease-modifying therapies.
Right Patient, Right Treatment, Right Time: Utilizing Early, High-Efficacy Therapies to Improve Outcomes in RRMS

Right Patient, Right Treatment, Right Time: Utilizing Early, High-Efficacy Therapies to Improve Outcomes in RRMS | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists
In this CME Outfitters virtual symposium, expert faculty will focus on the prognostic factors that should be considered when developing treatment plans for patients with MS, as well as the latest clinical data on approved and emerging DMTs, so that clinicians can confidently develop tailored treatment approaches based on individual patient characteristics and appropriately monitor treatment response, safety, and tolerability.
Next-Generation S1P Modulators in MS Management

Next-Generation S1P Modulators: Clinical Implications of Higher Selectivity in MS Management | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists
Multiple sclerosis (MS) management requires balancing the benefits of medications aimed at inhibiting inflammation and immunosuppression or immunomodulation against the risks of serious adverse effects and other drawbacks, such as the inconvenience and discomfort of infusions or injections. In this roundtable discussion, 2 experts in MS management review current and investigational treatments with a focus on newer sphingosine 1-phosphate (S1P) receptor modulators.
Optimizing Patient Outcomes in Myasthenia Gravis With Timely Diagnosis and Targeted Therapy

Optimizing Patient Outcomes in Myasthenia Gravis With Timely Diagnosis and Targeted Therapy | myCME

AMA PRA Category 1 Credit(s)TM
In this first myCME™ Expert Perspectives activity in a series of 2 programs, clinical experts in the management of patients with myasthenia gravis (MG) discuss the scope of the problem of the disease and strategies to promote timely and appropriate diagnosis. Evidence-based first-line MG treatment strategies will be reviewed, as will the potential limitations of these therapies.
Optimizing Management of Myasthenia Gravis With Novel Targeted Therapy

Optimizing Management of Myasthenia Gravis With Novel Targeted Therapy | myCME

AMA PRA Category 1 Credit(s)TM
During this myCME ™ Expert Perspectives roundtable discussion, 3 distinguished faculty discuss new understandings of the immunologic processes involved in the development of myasthenia gravis (MG,) the novel agents that target these processes, and the most recent clinical evidence for efficacy and safety. The faculty will also discuss the potential advantages of newer agents over conventional MG agents.
Posterior Circulation Stroke: Diverse Presentations, Easily Mistaken

Posterior Circulation Stroke: Diverse Presentations, Easily Mistaken | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s)
Delays in recognition and treatment of posterior circulation stroke (PCS) can result in devastating clinical and functional outcomes. Understanding how the location of lesions in either the proximal, middle, or distal parts of the posterior circulation can help raise the index of suspicion for PCS, allowing for timely detection of the causative vascular lesions and prompt implementation of reperfusion therapy.

Click for More Neurology Courses

Next hm-section-front in Neurology CME Courses